Estrella Immunopharma, Inc. (ESLA) Ownership
ESLA ownership summary
as of October 17, 2026- Institutions
- 11.1% of shares outstanding
- Insiders
- 60.42% of shares outstanding
- Shares outstanding
- 43.5M
- Float
- 38.2M shares available to trade
- Short interest
- 1.23% 214K shares short
- Days to cover
- 5.19 short interest up 39.2% vs prior month
- Institutions 11.14%
- Insiders 60.42%
- Other investors 28.44%
ESLA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Armistice Capital, LLC | 9.14% | 4.0M | $1.7M | −123,780 (−3.0%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 0.96% | 417K | $179,246 | +34,383 (+9.0%) | June 30, 2026 |
| 3 | Geode Capital Management, LLC | 0.32% | 141K | $60,768 | −16,164 (−10.3%) | June 30, 2026 |
| 4 | Vanguard Fiduciary Trust Co | 0.15% | 65K | $27,916 | — | June 30, 2026 |
| 5 | BlackRock Inc | 0.12% | 52K | $22,374 | +12,143 (+30.4%) | June 30, 2026 |
| 6 | State Street Corp | 0.10% | 43K | $18,598 | — | June 30, 2026 |
| 7 | Renaissance Technologies Corp | 0.09% | 39K | $16,813 | −23,695 (−37.7%) | June 30, 2026 |
| 8 | Northern Trust Corp | 0.08% | 35K | $14,990 | +15,237 (+77.6%) | June 30, 2026 |
| 9 | U.S. Bancorp | 0.05% | 20K | $8,600 | +3,096 (+18.3%) | June 30, 2026 |
| 10 | Tower Research Capital LLC | 0.01% | 3,308 | $1,422 | −1,551 (−31.9%) | June 30, 2026 |
| 11 | UBS Group AG | <0.01% | 1,721 | $740 | −13,358 (−88.6%) | June 30, 2026 |
| 12 | The Toronto-Dominion Bank | <0.01% | 1,089 | $468 | — | June 30, 2026 |
| 13 | Wolverine Asset Management LLC | <0.01% | 468 | $201 | — | June 30, 2026 |
| 14 | Barclays PLC | <0.01% | 126 | $54 | +126 (0.0%) | June 30, 2026 |
| 15 | Caitong International Asset Management Co., Limited. | 0.00% | 2 | $1 | +2 (0.0%) | June 30, 2026 |
| 16 | Royal Bank of Canada | 0.00% | — | — | −6,600 (−100.0%) | June 30, 2026 |
| 17 | Jane Street Group LLC | 0.00% | — | — | −10,441 (−100.0%) | March 31, 2026 |
| 18 | Wells Fargo & Co | 0.00% | — | — | −264,388 (−100.0%) | June 30, 2026 |
| 19 | Quadrature Capital Limited | 0.00% | — | — | −27,781 (−100.0%) | March 31, 2026 |
| 20 | Citadel Advisors Llc | 0.00% | — | — | −64,394 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 6 holders added 65K shares and 10 cut 552K.
ESLA top mutual fund and ETF holders
6 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 0.62% | 269K | $115,500 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.18% | 80K | $34,592 | −432 (−0.5%) | August 31, 2026 |
| 3 | iShares Micro-Cap ETF | 0.11% | 47K | $20,370 | −327 (−0.7%) | September 30, 2026 |
| 4 | Fidelity Series Total Market Index | 0.06% | 26K | $11,250 | — | August 31, 2026 |
| 5 | Fidelity Total Market Index | 0.04% | 17K | $7,208 | — | August 31, 2026 |
| 6 | 1290 VT Micro Cap K | 0.01% | 5,498 | $2,364 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ESLA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ESLA
Institutional investors own 11.1% of Estrella Immunopharma's shares and insiders 60.42%. The largest holder is Armistice Capital, LLC with 9.14% of the shares (4.0M), as of June 30, 2026. Among the top 20 institutions, 6 added shares and 10 reduced their stake in the latest filings. Short interest is 1.23% of the float, or 5.19 days of average trading volume. The share count rose 7.9% since 2021.
Related: ESLA analyst forecast, ESLA key metrics. See the ESLA stock overview for the latest quote and news.
ESLA ownership FAQ
Who owns the most Estrella Immunopharma stock?
The largest shareholders of Estrella Immunopharma are Armistice Capital, LLC (9.14%), Vanguard Capital Management, LLC (0.96%), Geode Capital Management, LLC (0.32%), Vanguard Fiduciary Trust Co (0.15%), BlackRock Inc (0.12%).
What percentage of Estrella Immunopharma is owned by institutions?
Institutions hold 11.1% of Estrella Immunopharma's shares outstanding; insiders hold 60.42%.
Which funds own Estrella Immunopharma?
The largest fund holders of Estrella Immunopharma are Vanguard MStar Total Stk Mkt Idx Invest (0.62%), Fidelity Extended Market Index (0.18%), iShares Micro-Cap ETF (0.11%), Fidelity Series Total Market Index (0.06%), Fidelity Total Market Index (0.04%).
What is Estrella Immunopharma's short interest?
214K shares of Estrella Immunopharma were sold short, 1.23% of the float; at the average daily volume it would take 5.19 days to cover.
How many shares of Estrella Immunopharma are outstanding?
Estrella Immunopharma has 43.5M shares outstanding, of which 38.2M are in the public float.